The uses of plant natural products by humans and risks associated with their use

Natural Products from Plants, Second Edition

Volumn , Issue , 2016, Pages 441-473

  Kaufman, Peter B ^a   Kirakosyan, Ara ^a   McKenzie, Maureen ^b   Dayanandan, P ^c   Hoyt, James E ^a   Li, Carl ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Denali BioTechnologies   (United States)

^c MADRAS CHRISTIAN COLLEGE   (India)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85129668157     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (124)

1. Adams, K.E., M.H. Cohen, D. Eisenberg, and A.R. Jonsen. (2002). Ethical considerations of complementary and alternative medical therapies in conventional medical settings. Ann Intern Med 137: 660-664.
2. Adler, S.R. and N.C. Showen. (1999). Pediatric complementary and alternative medicine use: physician-patient communication is vital. West J Med 171: 158.
3. Aggarwal, B.B., Y. Takada, and O.V. Oommen. (2004). From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Invest Drugs 13: 1327-1338.
4. Bagchi D., C.K. Sen, M. Bagchi, and M. Atalay. (2004). Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc) 69: 75-80.
5. Barnes, S., M. Kirk, and L. Coward. (1994). Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 42: 2466-2474.
6. Berman, J.D. and S.E. Straus. (2004). Implementing a research agenda for complementary and alternative medicine. Annu Rev Med 55: 239-254.
7. Bodeker, G. and F. Kronenberg. (2002). A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health 92: 1582-1591.
8. Bomser, J.A., D.L. Madhavi, K. Singletary, and M.A. Smith. (1995). Induction of NAD(P)H: (quinone-acceptor) oxido-reductase in murine hepatoma cells (Hepa 1c1c7) by fruit (Vaccinium) extracts. FASEB J 9: A993.
9. Bomser, J., D.L. Madhavi, K. Singletary, and M.A. Smith. (1996). In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med 62: 311-322.
10. Botta, B., G. Dell Monache, D. Misiti, A. Vitali, and G. Zappia. (2001). Aryltetralin lignans: chemistry, pharmacology and biotransformations. Curr Med Chem 8: 1363-1381.
11. Brokaw, J.J., G. Tunnicliff, B.U. Raess, and D.W. Saxon. (2002). The teaching of complementary and alternative medicine in U.S. medical schools: a survey of course directors. Acad Med 77: 876-881.
12. Buchanan, B.B., W. Gruissem, and R.L. Jones. (2000). Biochemistry and Molecular Biology of Plants. American Society of Plant Physiology, Rockville, Maryland.
13. Bulen, J.A., Jr. (2003). Greenwall Bioethics Award. Complementary and Alternative Medicine. Ethical and legal aspects of informed consent to treatment. J Leg Med 24: 331-358.
14. Casadesus, G., B. Shukitt-Hale, H.M. Stellwagen, X. Zhu, H.G. Lee, M.A. Smith, and J.A. Joseph. (2004). Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7: 309-316.
15. Cassileth, B.R. (1999). Evaluating complementary and alternative therapies for cancer patients. CA Cancer J Clin 49: 362-375.
16. Centers for Disease Control and Prevention. (1995a). Anticholinergic poisoning associated with an herbal tea - New York City, 1994. MMWR Morb Mortal Wkly Rep 44: 193-195.
17. Centers for Disease Control and Prevention. (1995b). Self-treatment with herbal and other plant-derived remedies - rural Mississippi, 1993. MMWR Morb Mortal Wkly Rep 44: 204-207.
18. Centers for Disease Control and Prevention. (1996). Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract - Colorado and Wyoming, 1995-1996. MMWR Morb Mortal Wkly Rep 45: 713-715.
19. Chambliss, L.R. (2001). Alternative and complementary medicine: an overview. Clin Obstet Gynecol 44: 640-652.
20. Chatterjee, A., T. Yasmin, D. Bagchi, and S.J. Stohs. (2004). Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin. Mol Cell Biochem 265: 19-26.
21. Cignarella, A., M. Nastasi, E. Cavalli, and L. Puglisi. (1996). Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res 84: 311-322.
22. Clark, P.A. (2000). The ethics of alternative medicine therapies. J Public Health Policy 21: 447-470.
23. Cohen, M.H. and D.M. Eisenberg. (2002). Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med 136: 596-603.
24. Conrick, J. (2001). Neem: The Ultimate Herb. Lotus Press, Twin Lakes, Wisconsin.
25. Cristoni, A., S. Malandrino, and M.J. Magistretti. (1989). Effect of a natural flavonoid on gastric mucosal barrier. Arzneimittelforschung 39: 590-592.
26. Das, D.K. (1994). Naturally occurring flavonoids: structure, chemistry, and high-performance liquid chromatography methods for separation and characterization. Methods Enzymol 234: 410-120.
27. Davis, M.P. and P.M. Darden. (2003). Use of complementary and alternative medicine by children in the United States. Arch Pediatr Adolesc Med 157: 393-396.
28. Dayanandan, P. and J. Ponsamuel. (2000). Ultrastructure of terpenoid secretory cells of neem (Azadirachta indica A. Juss.). In Electron Microscopy in Medicine and Biology, P.D. Gupta and H. Yamamoto (Eds.). Oxford & I.B.H. Publishing Co., New Delhi, India.
29. Dixon, R.A. and N.L. Paiva. (1995). Stress-induced phenylpropanoid metabolism. Plant Cell 7: 1085-1097.
30. Doyle, A. (2001). Alternative medicine and medical malpractice. Emerging issues. J Leg Med 22: 533-552.
31. Duffy, S.J. and J.A. Vita. (2003). Effects of phenolics on vascular endothelial function. Curr Opin Lipidol 14: 21-27.
32. Duke, J.A. (1981). Handbook of Legumes of World Economic Importance. Plenum Press, New York.
33. Edenharder, R., P. Kurz, K. John, S. Burgard, and K. Seeger. (1994). In vitro effect of vegetable and fruit juices on the mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline,2-amino-3,4-dimethylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Food Chem Toxicol 32: 443-459.
34. Eisenberg, D.M. (1997). Advising patients who seek alternative medical therapies. Ann Intern Med 127: 61-69.
35. Eisenberg, D.M., R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins, and T.L. Delbanco. (1993). Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328: 246-252.
36. Eisenberg, D.M., M.H. Cohen, A. Hrbek, J. Grayzel, M.I. Van Rompay, and R.A. Cooper. (2002). Credentialing complementary and alternative medical providers. Ann Intern Med 137: 965-973.
37. Ernst, E. (2003a). Cardiovascular adverse effects of herbal medicines: a systematic review of the recent literature. Can J Cardiol 19: 818-827.
38. Ernst, E. (2003b). Complementary medicine: where is the evidence? J Fam Pract 52: 630-634.
39. Ernst, E. and M.H. Cohen. (2001). Informed consent in complementary and alternative medicine. Arch Intern Med 161: 2288-2292.
40. Ferguson, P.J., E. Kurowska, D.J. Freeman, A.F. Chambers, and D.J. Koropatnick. (2004). A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134: 1529-1535.
41. Foo, L.Y., Y. Lu, A.B. Howell, and N. Vorsa. (2000). A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 63: 1225-1228.
42. Frenkel, M. and E. Ben Arye. (2001). The growing need to teach about complementary and alternative medicine: questions and challenges. Acad Med 76: 251-254.
43. Geller, J., L. Sionit, C. Partido, L. Li, X. Tan, T. Youngkin, D. Nachtshein, and R.M. Hoffman. (1998). Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 34: 75-79.
44. Gruenwald, J. (Ed.). (2004). PDR for Herbal Medicines. Medical Economics Company, Montvale, New Jersey.
45. Gu, L., M.A. Kelm, J.F. Hammerstone, G. Beecher, J. Holden, D. Haytowitz, S. Gebhardt, and R.L. Prior. (2004). Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134: 613-617.
46. Heck, A.M., B.A. DeWitt, and A.L. Lukes. (2000). Potential interactions between alternative therapies and warfarin™. Am J Health Syst Pharm 57: 1221-1227; quiz 1228-1230.
47. Heinonen, M., A.S. Meyer, and E.N. Frankel. (1998). Antioxidant activity of berry phenolics on human low-density lipoprotein and liposome oxidation. J Agric Food Chem 46: 4107-4112.
48. Hoffman, F.A. (2001). Regulation of dietary supplements in the United States: understanding the dietary supplement health and education act. Clin Obstet Gynecol 44: 780-788.
49. Howell, A.B. (2002). Cranberry proanthocyanidins and the maintenance of urinary tract health. Crit Rev Food Sci Nutr 42: 273S-278S.
50. Hubbard, G.P., J.M. Stevens, M. Cicmil, T. Sage, P.A. Jordan, C.M. Williams, J.A. Lovegrove, and J.M. Gibbins. (2003a). Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 1: 1079-1088.
51. Hubbard, G.P., S. Wolffram, J.A. Lovegrove, and J.M. Gibbins. (2003b). The role of polyphenolic compounds in the diet as inhibitors of platelet function. Proc Nutr Soc 62: 469-478.
52. Hughes, E.F. (2001). Integrating complementary and alternative medicine into clinical practice. Clin Obstet Gynecol 44: 902-906.
53. Izzo, A.A. and E. Ernst. (2001). Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175.
54. Jaakola, L., K. Maatta-Riihinen, S. Karenlampi, and A. Hohtola. (2004). Activation of flavonoid biosynthesis by solar radiation in bilberry (Vaccinium myrtillus L.) leaves. Planta 218: 721-728.
55. Jayaprakasam, B., S.K. Vareed, L.K. Olson, and M.G. Nair. (2005). Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53: 28-31.
56. Joseph, J.A. (2004). Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7: 309-316.
57. Joseph, J.A., B. Shukitt-Hale, and G. Casadesus. (2005). Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 81: 313S-316S.
58. Katsube, N., K. Iwashita, T. Tsushida, K. Yamaki, and M. Kobori. (2003). Induction of apoptosis in cancer cells by bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 51: 68-75.
59. Kessler, R.C. et al. (2001). The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158: 289-294.
60. Keung, W.M., O. Lazo, L. Kunze, and B.L. Vallee. (1995). Daidzin suppresses ethanol consumption by Syrian Golden hamsters without blocking acetaldehyde metabolism. Proc Natl Acad Sci USA 92: 8990-8993.
61. Keung, W.M. (Ed.). (2002). Pueraria. Taylor & Francis, New York.
62. Ko, R. (1999). Adverse reactions to watch for in patients using herbal remedies. West J Med 171: 181-186.
63. Koes, R., W. Verweij, and F. Quattrocchio. (2005). Flavonoids: a colorful model for the regulation and evolution of biochemical pathways. Trends in Plant Sci 10: 236-242.
64. Koul, O. and S. Wahab (Eds.). (2004). Neem: Today and in the New Millennium. Kluwer Academic Publishers, Dordrecht, The Netherlands.
65. Kroon, P.A., M.N. Clifford, A. Crozier, A.J. Day, J.L. Donovan, C. Manach, and G. Williamson. (2004). How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80: 15-21.
66. Lashof, J.C., S. Margen, and J.E. Swartzberg. (2002). Regulating natural health products. Science 296: 46-47.
67. Li, Y., S. Upadhyay, M. Bhuiyan, and S.H. Sarkar. (1999). Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18: 3166-3172.
68. Lietti, A. (1976). Studies on Vaccinium myrtillus anthocyanosides, I: vasoprotective and anti-inflammatory activity. Arzneimittelforschung 26: 829-832.
69. Lin, R.C., S. Guthrie, C.-I. Xie et al. (1996). Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharamacogenic rat model for alcoholism. Alcohol Clin Exp Res 20: 659-663.
70. Linde, K., W.B. Jonas, D. Melchart, and S. Willich. (2001). The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 30: 526-531.
71. Little, C. and T. Parsons. (2001). Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev 1: CD002948.
72. Logan, A.C. and C. Wong. (2001). Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev 6: 450-459.
73. Lu, X.R., S.M. Chen, and T. Sun. (1980). Study of B-adrenergic receptor blocking effect of extracum of root Pueraria hirsute. Acta Pharmacol Sin 15: 218-222.
74. Lukas, S.E., L.H. Lundahl, M. Lachance, S. Duggan, M. Stull, and D.Y. Lee. (1999). The Chinese herb, kudzu, alters ethanol effects in male and female subjects. The College on the Problems of Drug Dependence, Acapulco, Mexico.
75. Manach, C., A. Scalbert, C. Morand, C. Remesy, and L. Jimenez. (2004). Polyphenols: food sources and bioavailability. Am J Clin Nutr 79: 727-747.
76. Mazza, G. and B.D. Oomah. (2000). Herbs, Botanicals, and Teas as Functional Foods and Nutraceuticals, Technomic, Lancaster, Pennsylvania.
77. McGhie, T.K., G.D. Ainge, L.E. Barnett, J.M. Cooney, and D.J. Jensen. (2003). Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats. J Agric Food Chem 51: 4539-4548.
78. McKenzie, M.A. (2004). www.denali-biotechnologies.com.
79. Messina, M., V. Persky, K.D.R. Setchell, and S. Barnes. (1994). Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131.
80. Middleton, E. Jr., C. Kandaswami, and T.C. Theoharides. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
81. Miller, K.L., R.S. Liebowitz, and L.K. Newby. (2004). Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 147: 401-411.
82. Murphy, B.T., S.L. MacKinnon, X. Yan, G.B. Hammond, A.J. Vaisberg, and C.C. Neto. (2003). Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agri Food Chem 51: 3541-3545.
83. Nahin, R.L. and S.E. Straus. (2001). Research into complementary and alternative medicine: problems and potential. Brit Med J 322: 161-164.
84. National Research Council. (2002). Neem: A Tree for Solving Global Problems. (Noel Vietmeyer, Ed.). National Academy Press, Washington, D.C.
85. Neem. (2004). Neem - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. Icon Health Publications, San Diego, California.
86. Niggemann, B. and C. Gruber. (2003). Side-effects of complementary and alternative medicine. Allergy 58: 707-716.
87. Norten, E. (1999). Neem: India's Miraculous Healing Plant. J. Putz (Ed.). Healing Arts Press. Rochester, Vermont.
88. Petlevski, R., M. Hadzija, M. Slijepcevic, D. Juretic, and J. Petrik. (2003). Glutathione S-transferases and malondialdehyde in the liver of NOD mice on short-term treatment with plant mixture extract P-9801091. Phytother Res 17: 311-314.
89. Piscitelli, S.C., A.H. Burstein, D. Chaitt, R.M. Alfaro, and J. Falloon. (2000). Indinavir concentrations and St. John's wort. Lancet 355: 547-548.
90. Prior, R.L. (2003). Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr 78: 570S-578S.
91. Prior, R.L., G. Cao, A. Martin, E. Sofic, J. McEwen, C. O'Brien, N. Lischner, M. Ehlenfeldt, W. Kalt, G. Krewer, and C.M. Mainland. (1998). Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity, and variety of Vaccinium species. J Agric Food Chem 46: 2686-2693.
92. Prior, R.L., S.A. Lazarus, G. Cao, H. Muccitelli, and J.F. Hammerstone. (2001). Identification of procyanidins and anthocyanins in blueberries and cranberries (Vaccinium spp.) using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 49: 1270-1276.
93. Puri, H.S. (1999). Neem: The Divine Tree, Azadirachta indica. (Medicinal and Aromatic Plants, Industrial Profiles). CRC Press, Boca Raton, Florida.
94. Reed, J. (2002). Cranberry flavonoids, atherosclerosis and cardiovascular health. Crit Rev Food Sci Nutr 42: 301-316.
95. Rezvani, A.H. et al. (2003). Plant derivatives in the treatment of alcohol dependency. Pharmacol Biochem and Behav 75: 593-606.
96. Rimando, A.M., W. Kalt, J.B. Magee, J. Dewey, and J.R. Ballington. (2004). Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J Agric Food Chem 52: 4713-4719.
97. Sampson, W. (2001). The need for educational reform in teaching about alternative therapies. Acad Med 76: 248-250.
98. Schmidt, B.M., A.B. Howell, B. McEniry, C.T. Knight, D. Seigler, J.W. Erdman, Jr., and M.A. Lila. (2004). Effective separation of potent antiproliferation and antiadhesion components from wild blueberry (Vaccinium angustifolium Ait.) fruits. J Agric Food Chem 52: 6433-6442.
99. Schmutterer, H. (Ed.). (1995). The Neem Tree, Source of Unique Natural Products for Integrated Pest Management, Medicine, Industry and Other Purposes. VCH Publishers, Weinheim, Germany.
100. Seeram, N.P., R.A. Momin, M.G. Nair, and L.D. Bourquin. (2001). Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 8: 362-369.
101. Sellappan, S., C.C. Akoh, and G. Krewer. (2002). Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. J Agric Food Chem 50: 2432-2438.
102. Singh, R.P. and R.C. Saxena. (1999). Azadirachta indica A. Juss. Science Publishers, Enfield, New Hampshire.
103. Singh, R.P., M.S. Chari, A.K. Raheka, and W. Kraus. (Eds.). (1996). Neem and Environment. Vols. I and II. Oxford & I.B.H. Publishing, New Delhi, India.
104. Soeken, K.L. (2004). Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews. Clin J Pain 20: 13-18.
105. Starr, M.C.I. (2003). The evolution of The Cochrane Library, 1988-2003. Update software: Oxford (www.up-date-software.com/history/clibhist.htm). Accessed 23 March 2004.
106. Steinberg, D., M. Feldman, I. Ofek, and E.I. Weiss. (2005). Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Antimicrob Agents 25: 247-251.
107. Talalay, P. (2001). The importance of using scientific principles in the development of medicinal agents from plants. Acad Med 76: 238-247.
108. Taruscio, T.G., D.L. Barney, and J. Exon. (2004). Content and profile of flavanoid and phenolic acid compounds in conjunction with the antioxidant capacity for a variety of Northwest Vaccinium berries. J Agric Food Chem 52: 3169-3176.
109. Tewari, D.N. (1992). Monograph on Neem (Azadirachta indica A. Juss.). International Book Distributors, Dehra Dun, India.
110. The American Society for Clinical Nutrition. (2005). Proceedings of the First International Conference on Polyphenols and Health. Am J Clin Nutr 81: 215S-335S.
111. Thorne Research, Inc. (2001). Monograph, Vaccinium myrtillus (bilberry). Altern Med Rev 6: 500-504.
112. Trachtenberg, D. (2002). Alternative therapies and public health: crisis or opportunity? Am J Public Health 92: 1566-1567.
113. Tunon, H., C. Olavsdotter, and L. Bohllin. (1995). Evaluation of anti-inflammatory activity of some Swedish medicinal plants. Inhibition of prostaglandin biosynthesis and PAF-induced exocytosis. J Ethnopharmacol 48: 61-76.
114. VDF FutureCeuticals, Inc. (2003). www.futureceuticals.com.
115. Werneke, U., J. Earl, C. Seydel, O. Horn, P. Crichton, and D. Fannon. (2004). Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90: 408-413.
116. Wetzel, M.S., D.M. Eisenberg, and T.J. Kaptchuk. (1998). Courses involving complementary and alternative medicine at US medical schools. JAMA 280: 784-787.
117. Whitsett, S.F., R. Anderson, and M.J. Coppes. (1999). Why are children with cancer being exposed to complementary medicine? West J Med 171: 150-151.
118. Williams, R.J., J.P. Spencer, and C. Rice-Evans. (2004). Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849.
119. Williamson, G. (2003). Common features in the pathways of absorption and metabolism of flavonoids. In Phytochemicals: Mechanisms of Action, M.S. Meskin, W.R. Bidlack, A.J. Davies, D.S. Lewis, and R.K. Randolph (Eds.). CRC Press, Boca Raton, Florida, pp. 21-33.
120. World Health Organization. (2004). Traditional medicine. www.who.int/medicines/organization/trm/orgtrmmain.shtml (accessed March 24, 2004).
121. Yamanaka, A., R. Kimizuka, T. Kato, and K. Okuda. (2004). Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation, Oral Microbiol Immunol 19: 150-154.
122. Youdim, K.A., J. McDonald, W. Kalt, and J.A. Joseph. (2002). Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem 13: 282-288.
123. Zeng, G.Y., Y.P. Zhoe, L.Y. Zhang, and L.L. Fan. (1974). Effects of kudzu (Radix pueraria) on blood pressure, reaction ability of blood vessel, cerebrial and peripheral circulation in dog. Chin Med J 4: 265-257.
124. Zhao, C., M.M. Giusti, M. Malik, M.P. Moyer, and B.A. Magnuson. (2004). Effects of commercial anthocyanin-rich extracts on colonic cancer and non-tumorigenic colonic cell growth. J Agric Food Chem 52: 6122-6128.